Primary Care Enhanced Services
Overview
Summary, notice description and lot information
NHS Lincolnshire Integrated Care Board is set to award a contract for "Primary Care Enhanced Services" under the Provider Selection Regime regulations, focusing on general-practitioner services. This intent notice initiates the standstill period as of 2nd September 2025, with provider representations due by 12th September 2025. The contract, valued at £64,921, covers essential services such as phlebotomy, treatment room services, specialised drug monitoring, and more.
Spanning from 1st April 2025 to 31st March 2026, the procurement is managed through a limited method without prior competition publication, due to the PSR. The process is concluded by a final decision of the NHS Lincolnshire ICB's decision-makers, ensuring integration and innovation based on strict criteria. This procurement offers a significant growth opportunity primarily for small to medium-sized enterprises that specialise in healthcare services, particularly those in primary care or with capabilities in specialised services like DVT management and safeguarding.
Given the contract's emphasis on quality, value, and reducing health inequalities, businesses in the healthcare sector with a focus on social value and sustainability will find this tender particularly advantageous. The limited competition process leverages existing provider relationships, ensuring continuity of care and service integration, making it an ideal scenario for businesses already familiar with service delivery under the NHS framework.
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Leg Ulcer - Pessaries - Warfarin - DOAC - Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - Spirometry - Minor Injuries - DVT Assessment & Management including D-Dimer Testing - Ambulatory ECG
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Leg Ulcer - Pessaries - Warfarin - DOAC - Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - Spirometry - Minor Injuries - DVT Assessment & Management including D-Dimer Testing - Ambulatory ECG The contract duration is from 1st April 2025 to 31st March 2026 and the expected value of the activity for the lifetime of the contract is PS64,921. The provider is an existing provider and the services are existing services.
Procurement Classification
Notice type, method, and CPV codes
Contract Values
Financial information and value estimates
Contract duration information not available.
Key Dates
Publication, submission, and award timeline
Notice Status
Current status of tender, lots, awards, and contracts
Contracting Authority
Buyer organisation and contact details
Awarded Supplier
Supplier who was awarded this contract
Documents & Links
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Need help with your tender submission?
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact UsBidding for contracts like this
Other tenders in North Kesteven
- Environmental Controls - Direct Award Process C in North Kesteven
- Specialist Neighbourhood Nurses Services in North Kesteven
- Musculoskeletal and Spinal Service in North Kesteven
- Market Engagement - NHS Lincolnshire ICB - Night Light Cafes Service in North Kesteven
- GP Practice Medical Cover for Hospice in the Hospital in North Kesteven
- Musculoskeletal and Spinal Service in North Kesteven